Navigation Links
Ohio Ranks Best in the Midwest for Venture Capital Investment in Health Care Bioscience Industry
Date:8/19/2007

Strategic location and cross-collaboration throughout bioscience industry

attracts investors

COLUMBUS, Ohio, Aug. 14 /PRNewswire/ -- A new report ranks Ohio best in the Midwest for venture capital investments in biotech innovation and business growth, according to the Ohio Business Development Coalition (OBDC), the nonprofit organization that markets the state for capital investment. The report, released by BioEnterprise, a Cleveland, Ohio-based bioscience incubator, shows Ohio led all other Midwestern states with $244.3 million in health care related biotech investments in 24 companies.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070814/CLTU009LOGO )

"National investors are beginning to recognize that Ohio's strategic location in the Midwest region is ideal for growing businesses in the bioscience industry," said Baiju Shah, president of BioEnterprise. "Ohio has always been rich in research and industry assets. That rich base is now translating into a growing stream of high quality business growth due to progressive policies and programs through state investments in research and development."

Health care startups across the Midwest saw the largest growth, reporting a stunning $742 million in total investments across 64 companies in the first half of 2007 - nearly the same amount in total investments for all of 2006. Ohio far exceeded all competitors both in venture capital funding, number of investments and dollar amount of investment deals.

"In all aspects of biotech, from life sciences to health-care technologies to agriculture and food science, Ohio is at the heart of development and innovation in bioscience," said Ed Burghard, executive director for the Ohio Business Development Coalition. "The state is also attractive to executives because of its unique mix of micropolitan and metropolitan city structures. This distinctive combination provides executives the resources and time to pursue both their professional goals and personal aspirations without having to compromise one for the other. Ohio truly is the state of perfect balance."

The state's strong support for biotech and health care related bioscience companies is a result of Ohio's strengths and leadership in the three main bioscience industry sectors defined as Red (health), Green (agriculture) and White (industrial), according to the OBDC. Ohio's encouragement of cross- collaboration among the Red, Green and White industries uniquely positions the state to provide national leadership in all areas of bioscience.

"Ohio's bioscience community continues to grow, resulting in increased capital investment and new, high-paying jobs for Ohioans," said Burghard.

With more than $1 billion in funding and 775 bioscience entities operating throughout the state, Ohio is establishing an international leadership role in the cutting-edge bioscience industry. The Red, Green, White model is based on the three main bioscience industry sectors established by European bioscience leaders. Ohio's Red, Green and White bioscience entities generate more than $5.2 billion in direct economic impact and employ more than 37,000 skilled workers.

Ohio also has a budding culture of collaboration between entrepreneurs and large companies thanks in large part to the Third Frontier Project, a $1.6 billion initiative to help catalyze connections between companies and academia.

About the Ohio Business Development Coalition

The Ohio Business Development Coalition is a nonprofit organization that provides marketing strategy and implementation to support Ohio's economic development efforts. For more information, visit http://www.ohiomeansbusiness.com.


'/>"/>
SOURCE Ohio Business Development Coalition

Copyright©2007 PR Newswire.

Related biology technology :

1. Wisconsin ranks 30th in New Economy index
2. Madison again ranks as most digitized city
3. Aurora ranks among most wired systems
4. UW-Madison MBA ranks 51st in U.S., from no ranking last year
5. New guide ranks UW-Madison tops in research
6. Wisconsin ranks low in mid-year health care capital investment report
7. Midwest life science stocks kept sizzling in Q2
8. Midwest life science stocks sizzle in a tepid first quarter
9. A Midwest passage to India, Part II
10. Midwest offers non-stop flight to North Carolina research park
11. A Midwest life-science odyssey comes full circle
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... PARSIPPANY, N.J. , Feb. 24, 2017 /PRNewswire/ ... botanicals and biotechnology are now the fastest growing ... the Specialty Actives in Personal Care: Multi-regional ... market research and management consulting firm Kline. ... using bioprocesses that make them more effective for ...
(Date:2/24/2017)... 24, 2017  OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), ... a Key Opinion Leader event to highlight new clinical ... poster presentation at the upcoming 2017 ASCO-SITC Immuno-Oncology Symposium ... will be held in-person and via live webcast on ... AM PST at the Lotte New York Palace Hotel ...
(Date:2/23/2017)... , Feb. 23, 2017  MIODx announced today ... two key immunotherapy technologies from the University of ... a method to monitor a patient for response ... and CTLA-4.  The second license extends the technology ... is likely to have an immune-related adverse event ...
(Date:2/23/2017)... , ... February 23, 2017 ... ... announced today that in a published evaluation of multiple immunoassay-based threat detection ... Department of Energy Laboratory, PathSensors’ CANARY® biosensor threat detection technology was found ...
Breaking Biology Technology:
(Date:2/7/2017)... York , February 7, 2017 ... ID Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or the ... and electronic transaction processing services, is pleased to announce ... the Company. Effective January 31, 2017, ... Board of Directors, CEO and President.  An experienced payment ...
(Date:2/3/2017)... -- Texas Biomedical Research Institute announced that its Board of Trustees ... the Institute,s new President and CEO. Dr. Schlesinger will take ... is currently the Chair of the Department of Microbial Infection ... Biology at Ohio State University. "We are delighted ... of Texas Biomed," said Dr. James O. Rubin , ...
(Date:2/2/2017)... JACKSONVILLE, Fla. , Feb. 2, 2017 /PRNewswire/ ... ), a clinical-stage immuno-oncology company specializing in the ... vaccines for the treatment of cancer and metastatic ... multi-gram scale-up and GMP manufacturing of a second ... T-cell vaccine targeting folate receptor alpha. The manufactured ...
Breaking Biology News(10 mins):